Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,248,578
-
Share change
-
-240,912
-
Total reported value
-
$2,392,619,551
-
Put/Call ratio
-
123%
-
Price per share
-
$124.48
-
Number of holders
-
161
-
Value change
-
-$20,154,459
-
Number of buys
-
101
-
Number of sells
-
61
Institutional Holders of CHINA BIOLOGIC PRODS INC - COM (CBPO) as of Q3 2016
As of 30 Sep 2016,
CHINA BIOLOGIC PRODS INC - COM (CBPO) was held by
161 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,248,578 shares.
The largest 10 holders included
Capital Research Global Investors, Capital World Investors, BAILLIE GIFFORD & CO, FMR LLC, Invesco Ltd., FIL Ltd, Bank of New York Mellon Corp, Mirae Asset Global Investments Co., Ltd., BlackRock Fund Advisors, and HERMES INVESTMENT MANAGEMENT LTD.
This page lists
161
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.